Drugs / Repository corticotropin injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01966718 | Oct 2013 → Oct 2015 | rheumatoid arthritis | Arthritis Treatment Center, Maryland | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Repository corticotropin injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01966718 ↗ |
| Route | Subcutaneous | “80 United States Pharmacopeia (USP) Units per mL, dosed as 1 mL (80 Units) subcutaneous injection every 72 hours for 12 weeks” NCT01966718 ↗ |